Nanalysis Scientific Corp. (TSXV:NSCI)

Nanalysis Scientific Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.73	0.55	1.38	0.76	3.53	10.41
Cash & Short-Term Investments	0.73	0.55	1.38	0.76	3.53	10.41
Cash Growth	3.40%	-60.39%	81.29%	-78.47%	-66.12%	229.48%
Accounts Receivable	7.79	7.4	9.92	8.33	6.09	4.97
Other Receivables	0.83	1.11	1.15	1.43	2.9	1.13
Total Trade Receivables	8.62	8.5	11.07	9.76	8.98	6.1
Inventory	3.8	3.65	4.39	5.79	7.39	3.68
Other Current Assets	1.17	4.04	1.43	1.6	2.06	0.58
Total Current Assets	14.32	16.74	18.26	17.91	21.96	20.76
Net Property, Plant & Equipment	1.94	2.18	2.89	4.74	6.42	2.54
Other Intangible Assets	11.91	12.39	13.05	15.95	26.63	14.11
Goodwill	5.7	5.7	5.7	5.7	13.08	0.39
Long-Term Investments	-	-	-	5.73	-	-
Other Long-Term Assets	1.13	1.41	2.48	3.8	1.81	-
Total Assets	35	38.41	42.37	53.82	69.9	37.79

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.82	5.2	5.83	5.08	5.76	4.44
Short-Term Debt	2.23	2.8	2.8	2.9	2.54	-
Current Portion of Long-Term Debt	4.59	6.99	3.22	3.59	1.11	1.94
Current Portion of Leases	0.78	0.78	0.83	0.8	0.79	0.26
Unearned Revenue	1.46	1.25	1.19	1.32	1.93	1.8
Other Current Liabilities	0.19	0.18	0.52	0.91	1.38	0.21
Total Current Liabilities	14.07	17.2	14.38	14.6	13.51	8.65
Long-Term Debt	6.65	6.2	10.14	12.56	3.79	2.75
Long-Term Leases	0.62	0.81	1.38	2.13	2.53	1.04
Other Long-Term Liabilities	0.71	0.78	0.93	1.07	2.51	1.4
Total Long-Term Liabilities	7.98	7.8	12.45	15.75	8.82	5.19
Total Liabilities	22.05	24.99	26.83	30.34	22.33	13.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	60.82	60.2	57.57	53.2	49.02	31.3
Additional Paid-in Capital	7.19	6.97	6.15	5.03	3.94	2.19
Accumulated Other Comprehensive Income	0.49	0.51	0.43	0.24	0.97	0.17
Retained Earnings	-55.54	-54.26	-48.6	-34.99	-18.79	-9.69
Total Common Shareholders' Equity	12.95	13.42	15.55	23.48	35.13	23.96
Minority Interest	-	-	-	-	12.44	-
Shareholders' Equity	12.95	13.42	15.55	23.48	47.57	23.96
Total Liabilities & Equity	35	38.41	42.37	53.82	69.9	37.79

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	14.87	17.58	18.36	21.97	10.75	5.99
Net Cash (Debt)	-14.14	-17.03	-16.99	-21.21	-7.23	4.42
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.13	-0.15	-0.15	-0.21	-0.08	0.06
Book Value	12.95	13.42	15.55	23.48	35.13	23.96
Book Value Per Share	0.11	0.12	0.14	0.24	0.38	0.34
Tangible Book Value	-4.66	-4.67	-3.2	1.84	-4.58	9.47
Tangible Book Value Per Share	-0.04	-0.04	-0.03	0.02	-0.05	0.13

Data Source: Fiscal.ai Last updated: May 20, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error